Bühlmann Laboratories AG · Class II · Cleared Feb 6, 2024
| K-number | K232057 |
| Device name | BÜHLMANN fCAL® turbo and CALEX® Cap |
| Applicant | Bühlmann Laboratories AG |
| Product code | NXO |
| Device class | Class II |
| Decision date | Feb 6, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 866.5180 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov